Needham & Company upgraded Arena Pharma (NASDAQ: ARNA) from Hold to Buy with a price target of $60.00.Analyst Alan Carr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE